Analysis on the activated T-cells in lymphoproliferative diseases
淋巴细胞增殖性疾病中活化的 T 细胞分析
基本信息
- 批准号:13670814
- 负责人:
- 金额:$ 1.86万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Lymphoproliferative disease (LPD) is defined as a clonal disorder of lymphocytes without histopathological evidence of malignancy. Epstein-Barr virus (EBV) is reactivated and associated with the development of B-cell LPD in immunodeficient patients. This virus infects T/NK cells in immunocompetent subjects and induces EBV^+ T-cell LPD including chronic active EBV infection (CAEBV) and hemophagocytic lymphohistiocytosis (HLH). On the other hand, there is a group of inherited LPD caused by the defective functional molecule of T cells. Patients with primary HLH or autoimmune lymphoproliferative syndrome (ALPS) show hypercytokinemia or autoimmunity, because the cytotoxcity and activation-induced cell death (AICD) are impaired by the defects of perforin and Fas, respectively. Hyper-IgE syndrome (HIES) is a congenital immunodeficiency characterized by recurrent infections, marked IgE elevation, and increase of activated T cells. The defective IFNγ production is implicated in the pathogenesis … More of HIES. The present study revealed that the cytokines released from persistently activated T cells could contribute to the pathophysiology of these diseases.1) primary HLH: Perforin gene defects were found in 2/8 Japansese patients with familial HLH (FHL), and 1/7 patients without affected siblings (4 novel mutations). The protein was not expressed in CD8^+/CD56^+ cells of the patient. The frequency of mutation was 〜20% of FHL in Japan.2) ALPS: Patients with CD4^-CD8^- double negative (DN) αβT-cell expansion showed high serum IL-10 levels. IL-10-expressing DNT cells were increased in patients with lymphoproliferation. Real-time PCR revealed 〜100 times higher IL-10, but not, IFNγ or TGFβ in DN than in single positive T-cells. IL-10 was exclusively expressed in DN αβ but not γδ-cells. Circulating DN αβT-cells may constitutively express IL-10 and contribute to the ALPS phenotype.3) HIES: Cytokine profile of HLA-DR^+ and DR^- T-cells was analyzed. IFNγ/IL-4 or IFNγ/IL-10 ratio in DR^+ T-cells of HIES was lower than each of chronic granulomatous disease (CGD). TGFβ/IL-4 ratio in DR^+ T-cells of HIES was lower than that of atopy or CGD. TGFβ/IL-4 in DR^- T-cells of HIES was also lower than that of atopy. The statistical analysis revealed that TGFβ/IL-4 ratios in DR^+ or DR^- T-cells were the most powerful parameters to distinguish HIES from atopy and/or CGD. The in vivo activated T-cells of HIES might not sufficiently express IFNγ and TGFβ genes to counteract on the IL-4 dependent IgE production. The reduced TGFβ expression may imply the indigenous T-cell defects of HIES. Less
淋巴细胞增生性疾病(LPD)是指一种无恶性组织病理学证据的淋巴细胞克隆性疾病。EB病毒(EBV)被重新激活,并与免疫缺陷患者的B细胞LPD的发展有关。该病毒感染免疫活性受试者的T/NK细胞,并诱导EBV^+ T细胞LPD,包括慢性活动性EBV感染(CAEBV)和噬血细胞性淋巴组织细胞增多症(HLH)。另一方面,存在一组由T细胞功能分子缺陷引起的遗传性LPD。原发性HLH或自身免疫性淋巴组织增生综合征(ALPS)患者表现出高细胞因子血症或自身免疫,因为穿孔素和Fas的缺陷分别削弱了细胞毒性和激活诱导的细胞死亡(AICD)。高IgE综合征(hyper-IgE syndrome,HIES)是一种以反复感染、IgE显著升高和活化T细胞增多为特征的先天性免疫缺陷。IFNγ产生缺陷与发病机制有关 ...更多信息 的他。目前的研究表明,从持续活化的T细胞释放的细胞因子可能有助于这些疾病的病理生理学。1)原发性HLH:穿孔素基因缺陷被发现在2/8例日本家族性HLH(FHL)患者和1/7例无受累同胞(4个新突变)。该蛋白在患者的CD 8 ^+/CD 56 ^+细胞中不表达。在日本,突变频率为FHL的约20%。2)ALPS:CD 4 ^-CD 8 ^-双阴性(DN)αβ T细胞扩增的患者显示高血清IL-10水平。IL-10表达的DNT细胞在淋巴细胞增生患者中增加。Real-time PCR显示DN中IL-10的表达比单个阳性T细胞高100倍,而IFNγ或TGFβ的表达则无明显差异。IL-10仅表达于DN αβ细胞,而不表达于DN γδ细胞。循环DN αβ T细胞可能组成性表达IL-10并参与ALPS表型。3)HIES:分析HLA-DR^+和DR^-T细胞的细胞因子谱。HIES组DR^+ T细胞中IFNγ/IL-4、IFNγ/IL-10比值均低于慢性肉芽肿病组(CGD)。HIES组DR^+ T细胞中TGFβ/IL-4比值低于过敏症组和CGD组。HIES组DR^-T细胞中TGFβ/IL-4比值也低于特应性组。统计学分析显示,DR^+或DR^-T细胞中TGFβ/IL-4比值是区分HIES与特应性和/或CGD的最有力参数。HIES的体内活化T细胞可能不充分表达IFNγ和TGFβ基因以对抗IL-4依赖性IgE的产生。TGFβ表达的降低可能暗示HIES的固有T细胞缺陷。少
项目成果
期刊论文数量(45)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ishizaki Y, et al.: "Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella"J Infect. (in press).
Ishizaki Y 等人:“循环水痘带状疱疹病毒 DNA 的定量用于内脏水痘的早期诊断”J Infect。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohga S, Nomura A, Takahata Y, Ihara K, Takada H, Wakiguchi H, Kudo Y, Hara T:: "Dominant expression of IL-10 but not IFN-γ in CD4^- CD8^- αβ T cells of autoimmune lymphoproliferative syndrome."Br J Haematol. 119. 535-538 (2002)
Ohga S、Nomura A、Takahata Y、Ihara K、Takada H、Wakiguchi H、Kudo Y、Hara T::“自身免疫性淋巴细胞增殖性 CD4^- CD8^- αβ T 细胞中 IL-10 的显性表达,而非 IFN-γ 的显性表达综合征。”Br J Haematol. 119. 535-538 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kogawa K, Kudoh J, Nagafuchi S, Katsuta H, Ohga S, et al.: "Phenotype of autoimmune polyglandular syndrome type I and genotype of AIRE gene in a Japanese family"Clinical Immunology. 103. 277-283 (2002)
Kokawa K,Kudoh J,Nagafuchi S,Katsuta H,Ohga S,等:“日本家族中自身免疫性多腺体综合征 I 型表型和 AIRE 基因的基因型”临床免疫学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takada H, Nomura A, Ohga S, Hara T: "IL-18 in hemophagocytic lymphohistiocytosis"Leukemia and Lymphoma. 42. 21-28 (2001)
Takada H、Nomura A、Ohga S、Hara T:“噬血细胞性淋巴组织细胞增多症中的 IL-18”白血病和淋巴瘤。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
大賀正一, 稲葉頌一: "小児輸血療法-安全で有効な輸血のために-(II.新生児の輸血 D.顆粒球輸血)"南江堂. 75~83 (2001)
Shoichi Ohga、Shoichi Inaba:“小儿输血疗法 - 安全有效的输血 - (II.新生儿输血 D. 粒细胞输血)” Nankodo 75~83 (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OHGA Shouichi其他文献
OHGA Shouichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OHGA Shouichi', 18)}}的其他基金
Research on the pathogenesis and treatment of Epstein-Barr virusassociated intractable diseases
EB病毒相关疑难杂症的发病机制及治疗研究
- 批准号:
21591388 - 财政年份:2009
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Therapeutic strategy and biological characterization of Epstein-Barr virus (EBV) infected cells in chronic active EBV infection
慢性活动性 EBV 感染中 Epstein-Barr 病毒 (EBV) 感染细胞的治疗策略和生物学特性
- 批准号:
19591255 - 财政年份:2007
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of pathogenesis and pathophysiology of congenital bone marrow failure for the establishment of the treatment strategy
先天性骨髓衰竭发病机制和病理生理学分析以制定治疗策略
- 批准号:
15591114 - 财政年份:2003
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
T-cell analysis on chronic active Epstein-Barr virus (EBV) infection and EBV-associated lymphoproliferative diseases
慢性活动性 Epstein-Barr 病毒 (EBV) 感染和 EBV 相关淋巴组织增生性疾病的 T 细胞分析
- 批准号:
11670766 - 财政年份:1999
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
孔道形成蛋白perforin-2通过介导抗原提呈促进体液免疫的功能及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:34 万元
- 项目类别:地区科学基金项目
Tim-3信号通路异常调控uNK细胞分泌perforin影响反复着床失败患者子宫内膜容受性的分子机制
- 批准号:81771656
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
H2A-Perforin融合蛋白对小鼠肝移植后免疫反应性的影响及机制
- 批准号:81070376
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
重组人抗Tac-Perforin免疫毒素的研制
- 批准号:39200045
- 批准年份:1992
- 资助金额:5.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeting Ischemia-Induced Autophagy Dependence in hepatocellular Carcinoma through Image-guided Locoregional Therapy
通过图像引导局部治疗靶向肝细胞癌中缺血诱导的自噬依赖性
- 批准号:
10585078 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Sensitization to RIPK1-dependent death as a strategy to enhance response of renal cell carcinoma (RCC) to immunotherapy
对 RIPK1 依赖性死亡的敏感性作为增强肾细胞癌 (RCC) 对免疫治疗反应的策略
- 批准号:
10721156 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Immunoepigenetic targeting of MHC regulators in FAP
FAP 中 MHC 调节因子的免疫表观遗传学靶向
- 批准号:
10677375 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
High-dimensional mass imaging of muscle for the mechanistic study of T cells in inclusion body myositis
肌肉高维质量成像用于 T 细胞在包涵体肌炎机制研究中的应用
- 批准号:
10669370 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Sex Differences in NK Cells Mediated by X-linked UTX
X连锁UTX介导的NK细胞性别差异
- 批准号:
10750843 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cells
通过聚焦超声引导控制 HER2 CAR T 细胞治疗乳腺癌脑转移
- 批准号:
10668038 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Activating Native Tumor Immunity with IL-33 Armored CARs
使用 IL-33 装甲 CAR 激活天然肿瘤免疫
- 批准号:
10744438 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy
阻断颗粒酶介导的免疫抑制以增强艾滋病毒疫苗的功效
- 批准号:
10673227 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Targeting the immunoproteasome as a novel therapeutic strategy for hemophagocytic lymphohistiocytosis
靶向免疫蛋白酶体作为噬血细胞性淋巴组织细胞增多症的新型治疗策略
- 批准号:
10741624 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别: